Module overview
Section 5 of 6 · Open sections

Required section · Section 5 of 6

Choose the next review step

A second case: EDTA venous blood collected 45 minutes ago is run on a Sysmex XN configuration. QC and calibration records are acceptable for the run, but that status does not resolve an individual result. The specimen is not visibly clotted, lipemic, or hemolyzed; that appearance does not exclude an analytic or morphology concern. The result table supplies every CBC component, the flag, and the RBC-histogram observation for this discrepant case. A prior result from 2 days ago was RBC 4.55 × 10^12/L, hemoglobin 11.7 g/dL, hematocrit 35.0%, MCV 77 fL, and MCHC 33.4 g/dL.

A delta check is a locally defined comparison of a current result with a prior comparable patient result using an allowed interval and time window. Here the discordant RBC/hematocrit and extreme MCHC make a delta review appropriate, not an automatic rejection. First verify identity and specimen integrity, then review flags/histograms and the smear. RBC clumps support the agglutination branch and a validated warming/repeat procedure; turbid plasma with disproportionate photometric hemoglobin supports the lipemia branch; visibly hemolyzed plasma supports the hemolysis/specimen-acceptability branch and recollection when required; spherocytes on smear support morphology documentation and the local morphology-review path. If none is supported, repeat or recollect only as local policy directs.

Second CBC case: complete result set, illustrative intervals, and review evidence.
Parameter or evidenceCurrent resultIllustrative interval, calculation, or review meaning
RBC2.60 × 10^12/L4.2–5.7 × 10^12/L; low
Hemoglobin11.8 g/dL13.0–17.0 g/dL; low
Hematocrit24.5%39–50%; low
MCV94.2 fL80–100 fL; calculated from hematocrit and RBC
MCH45.4 pg27–33 pg; calculated from hemoglobin and RBC
MCHC48.2 g/dL32–36 g/dL; calculated from hemoglobin and hematocrit
RDW-CV18.9%11.5–14.5%; distribution width relative to MCV
RDW-SD54 fL37–54 fL; histogram width at analyzer-defined height
WBC6.8 × 10^9/L4.0–11.0 × 10^9/L
Neutrophils60% (4.1 × 10^9/L)40–70% (1.5–7.5 × 10^9/L); absolute = 6.8 × 0.60
Lymphocytes30% (2.0 × 10^9/L)20–45% (1.0–4.0 × 10^9/L); absolute = 6.8 × 0.30
Monocytes7% (0.5 × 10^9/L)2–10% (0.2–0.8 × 10^9/L); absolute = 6.8 × 0.07
Eosinophils2% (0.1 × 10^9/L)0–6% (0.0–0.5 × 10^9/L); absolute = 6.8 × 0.02
Basophils1% (0.1 × 10^9/L)0–2% (0.0–0.2 × 10^9/L); absolute = 6.8 × 0.01
Platelets230 × 10^9/L150–400 × 10^9/L
MPV9.6 fL7.5–11.5 fL
Plateletcrit0.22%0.15–0.40%; 230 × 9.6 ÷ 10,000 = 0.2208%
Analyzer flag and histogramRBC distribution abnormality; irregular, broadened RBC histogramReview evidence, not a diagnosis
Specimen appearanceNo visible clot, lipemia, or hemolysisInspect again with identity and smear evidence; a visually clear specimen does not exclude all interference

Ordering exercise

Place the review actions in a defensible sequence for the discrepant second CBC.

  1. 1. Perform smear review

    Assess clumps, spherocytes, and other morphology only when local criteria or evidence support it.

  2. 2. Repeat, warm, or recollect by branch

    Use the locally validated agglutination, interference, or specimen-acceptability procedure.

  3. 3. Verify identity and inspect specimen

    Check identifiers and visible clot, agglutination, lipemia, hemolysis, or dilution concerns.

  4. 4. Review analyzer evidence

    Review flags, histograms, method card, QC/calibration status, and prior comparable result.

Knowledge checks

Reading and checks are open. Sign in only to save.

Knowledge check 1

Which evidence-action pair is appropriate for the second case?

Choose at least 3 options.

Knowledge check 2

If visible hemolysis is the supported cause of the discrepancy, what is the bounded action?

Choose one option.

Section status

Finish this section

Reading and checks are open. Sign in only to save.

The module finishes after every required section is marked done and every check in those sections is correct.